TY - JOUR T1 - Prediction of fluoroquinolone susceptibility directly from whole genome sequence data using liquid chromatography-tandem mass spectrometry to identify mutant genotypes JF - bioRxiv DO - 10.1101/138248 SP - 138248 AU - Wan Ahmad Kamil Wan Nur Ismah AU - Yuiko Takebayashi AU - Jacqueline Findlay AU - Kate J. Heesom AU - Juan-Carlos Jiménez-Castellanos AU - Jay Zhang AU - Lee Graham AU - Karen Bowker AU - O. Martin Williams AU - Alasdair P. MacGowan AU - Matthew B. Avison Y1 - 2017/01/01 UR - http://biorxiv.org/content/early/2017/05/16/138248.abstract N2 - Fluoroquinolone resistance in bacteria is multifactorial, involving target site mutations, reductions in fluoroquinolone entry due to reduced porin production, increased fluoroquinolone efflux, enzymes that modify fluoroquinolones, and Qnr, a DNA mimic that protects the drug target from fluoroquinolone binding. Here we report a comprehensive analysis using transformation and in vitro mutant selection, of the relative importance of each of these mechanisms in fluoroquinolone resistance and non-susceptibility, using Klebsiella pneumoniae, one of the most clinically important multi-drug resistant bacterial species known, as a model system. Our improved biological understanding was then used to generate rules that could be predict fluoroquinolone susceptibility in K. pneumoniae clinical isolates. Key to the success of this predictive process was the use of liquid chromatography tandem mass spectrometry to measure the abundance of proteins in extracts of cultured bacteria, identifying which sequence variants seen in the whole genome sequence data were functionally important in the context of fluoroquinolone susceptibility. ER -